BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35320511)

  • 1. Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab.
    Boesl F; Allers K; Herm J; Scheider T; Franke C
    J Neurovirol; 2022 Apr; 28(2):335-338. PubMed ID: 35320511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab.
    Varmpompiti K; Westwood AJ; Ben-Joseph A; Sibtain N; Ibrahim MAA; Stanton B; Zuckerman M; Hadden R; Ritter LM
    J Neuroimmunol; 2023 Dec; 385():578248. PubMed ID: 37995595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
    Holmes A; Wellings T; Walsh O; Rowlings P
    J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
    Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
    N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report.
    Cifci B; Yildiz Y; Altin E; Habibi H; Kocer B; Dizbay M
    J Neurovirol; 2023 Feb; 29(1):111-115. PubMed ID: 36795262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review.
    Lan TY; Chen YS; Cheng CF; Huang ST; Shen CY; Hsu PN
    Lupus; 2021 Oct; 30(11):1849-1855. PubMed ID: 34325541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
    Volk T; Warnatz K; Marks R; Urbach H; Schluh G; Strohmeier V; Rojas-Restrepo J; Grimbacher B; Rauer S
    J Neurol; 2022 Feb; 269(2):973-981. PubMed ID: 34196768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV.
    Pinnetti C; Cimini E; Vergori A; Mazzotta V; Grassi G; Mondi A; Forbici F; Amendola A; Grisetti S; Baldini F; Candela C; Casetti R; Campioni P; Capobianchi MR; Agrati C; Antinori A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pembrolizumab treatment of inflammatory progressive multifocal leukoencephalopathy: a report of two cases.
    Darcy S; Alexander M; McCarthy A; O'Dowd S
    J Neurovirol; 2022 Feb; 28(1):145-150. PubMed ID: 34874539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel treatments for progressive multifocal leukoencephalopathy.
    Bennett KM; Fernandes PM
    Br J Hosp Med (Lond); 2020 Jul; 81(7):1-9. PubMed ID: 32730143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pembrolizumab for the treatment of Progressive Multifocal Leukoencephalopathy (PML) in a patient with AIDS: A case report and literature review.
    Chatterjee T; Roy M; Lin RC; Almoujahed MO; Ahmad S
    IDCases; 2022; 28():e01514. PubMed ID: 35637642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.
    Bellizzi A; Nardis C; Anzivino E; Rodìo D; Fioriti D; Mischitelli M; Chiarini F; Pietropaolo V
    J Neurovirol; 2012 Feb; 18(1):1-11. PubMed ID: 22290500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab-associated progressive multifocal leukoencephalopathy.
    Sokol J; Lisá L; Zeleňáková J; Balhárek T; Plameňová I; Staško J; Kubisz P
    Vnitr Lek; 2017; 63(1):60-64. PubMed ID: 28225293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive multifocal leukoencephalopathy in patients with chronic kidney disease.
    Meylor J; Artunduaga DC; Mendoza M; Hooshmand SI; Obeidat AZ
    Neurol Sci; 2024 Apr; 45(4):1619-1624. PubMed ID: 37950135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
    Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen-sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximab.
    Toyoda M; Thomas D; Ahn G; Kahwaji J; Mirocha J; Chu M; Vo A; Suviolahti E; Ge S; Jordan SC
    Transpl Infect Dis; 2015 Dec; 17(6):838-47. PubMed ID: 26437369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multifocal leukoencephalopathy in the context of newer therapies in hematology and review of new treatment strategies.
    Diamantopoulos PT; Kalopisis K; Tsatsou A; Efthymiou A; Giannakopoulou N; Hatzidavid S; Viniou NA
    Eur J Haematol; 2022 May; 108(5):359-368. PubMed ID: 35100451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human polyomavirus JC latency and reactivation status in blood of HIV-1-positive immunocompromised patients with and without progressive multifocal leukoencephalopathy.
    Andréoletti L; Dubois V; Lescieux A; Dewilde A; Bocket L; Fleury HJ; Wattré P
    AIDS; 1999 Aug; 13(12):1469-75. PubMed ID: 10465069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging the Gap: Immunotherapy in Progressive Multifocal Leukoencephalopathy: A New Hope?
    Born T; Vassallo P; Golshayan D; Di Liberto G; Brouland JP; Egervari K; Merkler D; Du Pasquier RA; Bernard-Valnet R
    Neurology; 2023 Sep; 101(13):e1382-e1386. PubMed ID: 37407265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China.
    Fan S; Liu M; Bai L; Chen S; Hou B; Lin N; Yuan J; Mao C; Niu J; Ren H; Zhao Y; Zhang Z; Zhu Y; Peng B; Guan H
    J Neurovirol; 2023 Dec; 29(6):692-698. PubMed ID: 37898569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.